Cell study

DP Diana L. Philip
ES Elena A. Silantyeva
MB Matthew L. Becker
RW Rebecca K. Willits
ask Ask a question
Favorite

Materials used during this study included the following: D3 mESCs (ATCC); ES-qualified 0.1% gelatin (Embryomax, Millipore); D3 growth medium consisted of Dulbecco’s Modification of Eagle’s Medium (DMEM) (Corning) prepared with sodium bicarbonate (Sigma), supplemented with 10% ES-qualified fetal bovine serum (Millipore), 10−4 M β-mercaptoethanol (Millipore Embryomax), 4 mM L-glutamine (Life Technologies), 4.7 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Hyclone GE Healthcare), and 1000 units/mL human recombinant leukemia inducing factor (GlobalStem); trypsin-EDTA (Sigma Aldrich); flow cytometry antibodies: anti-SSEA1 (BioLegend 125606) and isotype control (BioLegend 401611); Neural differentiation medium consisted of 70% DMEM/F-12 (Corning), 20% neurobasal medium (Life Technologies), 1X N2 supplement, 20% PluriQ serum replacement (GlobalStem), 10−3 M sodium pyruvate (Sigma), 2 mM L-glutamine (Life Technologies), and 2 μM retinoic acid (Sigma). TRIzol reagent (Life Technologies); cDNA Synthesis Kit (Quantabio), SYBR Green (Quantabio). Paraformaldehyde (Fisher Scientific); Triton-X (Sigma); sodium borohydride (MP Biomedicals); Primary antibodies: NES (Abcam 134017; 1:10,000), SSEA1 (DSHB MC480; 1:8), OCT4 (Abcam 198857; 1:1000), SOX1 (Cell Signaling Tech 4194; 1:200), GFAP (BioLegend 82401; 1:1000), and TUBB3 (Abcam 78078; 1:500) for early time points (days 1 and 3); GFAP, TUBB3, MAP2 (Abcam 11267; 1:500), GAP43 (Abcam 16053; 1:500), and OLIG1 (Abcam 53041; 1:500). Nuclei stain: H33342 (Life Technologies H1399); Secondary antibodies were diluted at 1:400; goat anti-mouse IgM AF546 (Life Technologies A21045), donkey anti-rabbit IgG AF647 (Life Technologies A31573), goat anti-chicken IgY AF488 (Life Technologies A11039), goat anti-mouse IgG2a AF546 (Life Technologies A21133), and goat anti-mouse IgG1 AF546 (Life Technologies A21123).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A